ArticleScience progress
An improved deep learning-based MSA-Net model for small liver tumor segmentation.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveLiver cancer is one of the most fatal types of cancer in the world, and early identification is one of the most crucial considerations that may improve the likelihood of recovery. Hence, building a computer-aided diagnosis (CAD) system that improves radiologists' operations by providing automated, high-precision small-tumor segmentation in complicated medical imaging is the main objective of this research study.MethodsConventional deep learning techniques, like U-Net, have shown impressive overall tumor delineation results, but they frequently struggle to distinguish between large and small tumors. The occurrence of tiny tumors and tumors with different shapes in the intricate liver exacerbates this deficiency. This paper proposed an MSA-Net (Multi-Scale Attention Network), a variant of the U-Net architecture, to address these problems. This is accomplished by the effective extraction of small-tumor features, which is made possible by the architecture's integration of multi-scale convolutional layers into the encoder and decoder pathways, as well as an attention mechanism that concentrates on salient regions and gathers contextual data across several receptive fields.ResultsThe proposed MSA-Net was trained and tested using the publicly accessible 3DIRCADb and LiTS datasets. The 3Dircadb dataset yielded a dice score of 92.00% and a Jaccard index of 86.00% for small tumors, whereas the LiTS dataset yielded a dice score of 72.57% and a Jaccard index of 65.35% for small tumors.ConclusionIn contrast to other research, our technique assesses the outcomes by evaluating large and small tumors independently. The findings demonstrate that MSA-Net greatly improves segmentation, particularly in tiny tumors, demonstrating its usefulness in real-world clinical contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.